Visikol has announced that they will be partnering with Biopredic to launch liver 3D cell culture models for use in Visikol’s 3D cell culture assay services which leverage Biopredic’s HepaRG cells. WHITEHOUSE, N.J. A major goal for pharmaceutical companies has always been to improve the translational gap between inexpensive in vitro studies and significantly more

To read the full story...

Already a subscriber? Login now

< | >